Use of plerixafor with granulocyte colony-stimulating factor for stem cell mobilization in a pediatric patient

Annals of Pharmacotherapy

Volumn 45, Issue 2, 2011, Pages

  Bernardo, Valeria Alejandra ^a   Ng, John Szechung ^b   Joyce, Michael John ^c  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b WOLFSON CHILDREN S HOSPITAL   (United States)

^c Department of Medicine   (United States)

Author keywords

AMD3100; Granulocyte colony stimulating factor; Hematopoietic stem cell; Plerixafor; Stem cell mobilization

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; HYDROCORTISONE; IFOSFAMIDE; METHOTREXATE; PLERIXAFOR; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VINBLASTINE; VINCRISTINE; HETEROCYCLIC COMPOUND;

ADD ON THERAPY; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BRAIN METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; CD34 SELECTION; CERVICAL SPINAL CORD; CHILD; DRUG EFFICACY; DRUG SAFETY; FLOW CYTOMETRY; HUMAN; HUMERUS; INJECTION SITE REACTION; LARGE CELL LYMPHOMA; LEUKAPHERESIS; MALE; MULTIPLE CYCLE TREATMENT; NECK PAIN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARESTHESIA; PEDIATRICS; PRIORITY JOURNAL; SCHOOL CHILD; SINGLE DRUG DOSE; SPINAL CORD METASTASIS; STEM CELL MOBILIZATION; TREATMENT OUTCOME; TUMOR LOCALIZATION; TUMOR RECURRENCE; DRUG COMBINATION; LYMPHOMA, LARGE-CELL, ANAPLASTIC; PATHOLOGY; RECURRENT DISEASE;

CHILD; DRUG THERAPY, COMBINATION; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HETEROCYCLIC COMPOUNDS; HUMANS; LYMPHOMA, LARGE-CELL, ANAPLASTIC; MALE; RECURRENCE;

EID: 79951910750     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1P564     Document Type: Article

References (14)

1. Rosenbeck LL, Srivastava S, Kiel PJ. Peripheral blood stem cell mobilization tactics. Ann Pharmacother 2010;44:107-16. DOI 10.1345/aph.1M289
2. Choi H-Y, Yong C-S, Yoo BK. Plerixafor for stem cell mobilization in patients with non-Hodgkin's lymphoma and multiple myeloma. Ann Pharmacother 2010;44:117-26. DOI 10.1345/aph.1M380
3. Kessans MR, Gatesman ML, Kockler DR. Plerixafor: a peripheral blood stem cell mobilizer. Pharmacotherapy 2010;30:485-92. DOI 10.1592/phco.30.5.485
4. Vose JM, Ho AD, Coiffier B, et al. Advances in mobilization for the optimization of autologous stem cell transplantation. Leuk Lymphoma 2009;50:1412-21. DOI 1080/10428190903096701
5. Wagstaff AJ. Plerixafor: in patients with non-Hodgkin's lymphoma or multiple myeloma. Drugs 2009;69:319-26.
6. Gertz MA, Wolf RC, Micallef IN, Gastineau DA. Clinical impact and resource utilization after stem cell mobilization failure in patients with multiple myeloma and lymphoma. Bone Marrow Transplant 2010;45:1396-403. DOI 10.1038/bmt.2009.370
7. Uy GL, Rettig MP, Cashen AF. Plerixafor, a CXCR4 antagonist for the mobilization of hematopoietic stem cells. Expert Opin Biol Ther 2008;8:1797-804. DOI 10.1517/14712598.8.11.1797
8. Product Information. Mozobil (plerixafor injection) solution for subcutaneous use. Cambridge, MA: Genzyme Corporation, April 2010.
9. Flomenberg N, Comenzo RL, Badel K, Calandra G. Plerixafor (Mozobil) alone to mobilize hematopoietic stem cells from multiple myeloma patients for autologous transplantation. Biol Blood Marrow Transplant 2010;16:695-700 DOI 10.1016/j.bbmt.2009.12.538
10. Stiff P, Micallef I, McCarthy P, et al. Treatment with plerixafor in non- Hodgkin's lymphoma and multiple myeloma patients to increase the number of peripheral blood stem cells when given a mobilizing regimen of G-CSF: implications for the heavily pretreated patient. Biol Blood Marrow Transplant 2009;15:249-56. DOI 10.1016/j.bbmt.2008.11.028
11. DiPersio JF, Stadtmauer EA, Nadamanee A, et al. Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma. Blood 2009;113:5720-6. DOI 10.1182/blood-2008-08-174946
12. DiPersio JF, Micallef IN, Stiff PJ, et al. Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for patients with non-Hodgkin's lymphoma. J Clin Oncol 2009;27:4767-73.
13. Fowler CJ, Dunn A, Hayes-Lattin B, et al. Rescue from failed growth factor and/or chemotherapy HSC mobilization with G-CSF and plerixafor (AMD3100): an institutional experience. Bone Marrow Transplant 2009;43:909-17. DOI 10.1038/bmt.2008.409
14. Horwitz M, Schriber J, Libby EN, et al. Efficacy and safety of hematopoietic stem cell (HSC) remobilization with plerixafor plus G-CSF in patients with non-hematologic malignancies (abstract e15072). J Clin Oncol 2010;28:e15072.